CRRT
COUR Pharmaceutical Development Company, Inc.
Phase 2
Estimated
CNP-103
Type 1 Diabetes Mellitus
T-minus 177 days
~ Dec 31, 2026
ClinicalTrials.gov
verified 15h ago
Countdown card →